Southpoint Capital Advisors LP sold FENC
October 7, 2025 · Form 4 insider transaction
Southpoint Capital Advisors LP sold 26,900 shares of Fennec Pharmaceuticals Inc. at $9.59 per share, a transaction worth $257.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The transaction was executed in multiple trades at prices ranging from $9.47 to $9.70. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.; The securities are directly held by Southpoint Master Fund, LP for which Southpoint Capital Advisors LP serves as the investment manager and Southpoint GP, LP serves as the general partner. Southpoint Capital Advisors LLC serves as the general partner of Southpoint Capital Advisors LP and Southpoint GP, LLC serves as the general partner of Southpoint GP, LP. John S. Clark II serves as managing member of both Southpoint Capital Advisors LLC and Southpoint GP, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.